[HTML][HTML] Does Motor Symptoms Asymmetry Predict Motor Outcome of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients?
Background In Parkinson's disease (PD), the side of motor symptoms onset may influence
disease progression, with a faster motor symptom progression in patients with left side …
disease progression, with a faster motor symptom progression in patients with left side …
Follow-up of bilateral subthalamic deep brain stimulation for Parkinson's disease
Purpose To demonstrate the effects of bilateral subthalamic deep brain stimulation (STN-
DBS) in the treatment of Parkinson's disease (PD) after 4–45 months' follow-up. Method …
DBS) in the treatment of Parkinson's disease (PD) after 4–45 months' follow-up. Method …
What predicts quality of life after subthalamic deep brain stimulation in Parkinson's disease? A systematic review
VJ Geraedts, S Feleus, J Marinus… - European journal of …, 2020 - Wiley Online Library
Background and purpose Subthalamic deep brain stimulation (STN DBS) is an effective
therapy against medication‐refractory motor complications in patients with Parkinson's …
therapy against medication‐refractory motor complications in patients with Parkinson's …
The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus
A Shalash, A Alexoudi, K Knudsen, J Volkmann… - Parkinsonism & related …, 2014 - Elsevier
Background Selection of patients with Parkinson's disease for neurostimulation of
subthalamic nucleus (STN-DBS) is still poorly studied. Aim To identify the impact of age and …
subthalamic nucleus (STN-DBS) is still poorly studied. Aim To identify the impact of age and …
Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany
W Meissner, D Schreiter, J Volkmann, T Trottenberg… - Journal of …, 2005 - Springer
During the last few years, deep brain stimulation (DBS) of the subthalamic nucleus (STN)
has emerged as a promising therapy, alleviating major motor symptoms of Parkinson's …
has emerged as a promising therapy, alleviating major motor symptoms of Parkinson's …
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age
HS Dafsari, P Reker, L Stalinski… - Movement …, 2018 - Wiley Online Library
Objective The purpose of this study was to investigate how quality of life outcome after
bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease …
bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease …
Longitudinal medication profile and cost savings in Parkinson's disease patients after bilateral subthalamic nucleus deep brain stimulation
JH Ng, AAQ See, Z Xu, NKK King - Journal of Neurology, 2020 - Springer
Introduction Deep brain stimulation of the subthalamic nucleus (STN DBS) has been shown
to reduce antiparkinsonian medication in Parkinson's disease. We aimed to investigate the …
to reduce antiparkinsonian medication in Parkinson's disease. We aimed to investigate the …
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation
Objective To assess the 10-year motor outcome of deep brain stimulation of the subthalamic
nucleus (STN-DBS) in patients with Parkinson disease (PD). Design Patients with PD with …
nucleus (STN-DBS) in patients with Parkinson disease (PD). Design Patients with PD with …
[PDF][PDF] SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease
S Nunta-Aree, B Sitthinamsuwan, K Boonyapisit… - J Med Assoc …, 2010 - academia.edu
Background: Deep brain stimulation of the subthalamic nucleus (STN-DBS) is the recent
surgical treatment of choice for patients with idiopathic Parkinson's disease (PD) …
surgical treatment of choice for patients with idiopathic Parkinson's disease (PD) …
Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease
BACKGROUND: Bilateral subthalamic nucleus (STN) deep brain stimulation (DBS)
improves motor function in patients with medically intractable Parkinson's disease (PD), but …
improves motor function in patients with medically intractable Parkinson's disease (PD), but …